- B2B
- Early StageStartup in initial stages
Genome Compiler Funding
$0
22 rounds
NFX
Genome Compiler is active in the following markets / industries: biotechnology, SaaS, synthetic biology and bioinformatics. The company has secured funding across 2 rounds and is valued at $0. Their most recent funding was raised on April 6, 2016.
Funding Rounds
ACQ
Undisclosed amountAcquiredApr 2016
A
$5750000Investors of Genome Compiler
Advisor, investor & co-founder. Marin Software BOD; Recurrent Energy Co-founder & COB; Work.com Founder & CEO; Excite@Home GM/SVP; Netcom SVP, Sales & Mkt.
Angel Investor and Founder @ShopJimmy.com, 2010 Entrepreneur of the Year for Distribution Upper Midwest.
Founder @StartupIceland• Founder @IcelandVentureStudio @FoundersVentures • was@capgemini @Glitnir @Greenqloud •Investor @buuteeq @Clara Ma @GuideToIceland @Travelshift
Sean Moran
Seed and series A venture firm that is transforming how true innovators are funded
University of Cambridge (UK) Masters, Dartmouth College BA. Recovering Investment banker, startup consultant and investor. Ex-rower, current runner
Retired VC/Serial Entrepreneur Sold @BoomStartup to Assure. Micro VC Invested in 100+ Startups. Past Mentor & LP in @500 Global @Techstars.
GP @Motivate Ventures Founder @IrishAngels 100+investments @Chime @TradingView @Techstars @Change.org @Influitive @HomeChef @Appcast @Unsplash 4x Founder w/ successful exits
Knickerbocker Capital, LP. Fund investing in decentralized web at all stages.